Intensive strategy to prevent CMV disease in seropositive umbilical cord blood transplant recipients

Seropositive umbilical cord blood transplant (UCBT) recipients are at increased risk for CMV complications. To reduce CMV complications, we adopted an intensive strategy that consisted of ganciclovir administered before transplantation (5 mg/kg intravenously daily from day −8 to day −2), high-dose a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Milano, Filippo, Pergam, Steven A., Xie, Hu, Leisenring, Wendy M., Gutman, Jonathan A., Riffkin, Ivy, Chow, Victor, Boeckh, Michael J., Delaney, Colleen
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2011
Soggetti:
Clinical Trials and Observations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3217367/
https://ncbi.nlm.nih.gov/pubmed/21937692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-06-361618
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi